神经损伤与功能重建2024，Vol.19Issue(12)：P.F0003-F0003,1.DOI:10.16780/j.cnki.sjssgncj.202412026
可溶性TGF-β诱饵受体TGFBR3通过改变小胶质细胞功能加重阿尔茨海默病病理
Lijun Zhou 1Nan Wang 2Wenzheng Feng 1Xin Liu 2Qiong Wu 3Jiangxia Chen 1Xinming Jiao 1Xinyue Ning 1Zhentong Qi 1Zihua Xu 2Xiaowen Jiang 4Qingchun Zhao 2唐颖馨(编译)5
作者信息
- 1. Department of Clinical Pharmacy,Shenyang Pharmaceutical University,Shenyang,People''s Republic of China
- 2. Department of Clinical Pharmacy,Shenyang Pharmaceutical University,Shenyang,People''s Republic of China Department of Pharmacy,General Hospital of Northern Theater Command,Shenyang,People''s Republic of China
- 3. Department of Pharmacy,General Hospital of Northern Theater Command,Shenyang,People''s Republic of China
- 4. College of Traditional Chinese Pharmacy,Shenyang Pharmaceutical University,Shenyang,People''s Republic of China
- 折叠
摘要
关键词
APP/PS1小鼠/阿尔茨海默病/RNA测序/小胶质细胞/可溶性转化生长因子β受体3分类
医药卫生引用本文复制引用
Lijun Zhou,Nan Wang,Wenzheng Feng,Xin Liu,Qiong Wu,Jiangxia Chen,Xinming Jiao,Xinyue Ning,Zhentong Qi,Zihua Xu,Xiaowen Jiang,Qingchun Zhao,唐颖馨(编译)..可溶性TGF-β诱饵受体TGFBR3通过改变小胶质细胞功能加重阿尔茨海默病病理[J].神经损伤与功能重建,2024,19(12):P.F0003-F0003,1.
